Company
United StatesPublic company, NASDAQ: LXRXLexicon Pharmaceuticals Inc (NASDAQ: LXRX), Spring, TX – FDA Inspections
Inspection records and compliance data for Lexicon Pharmaceuticals Inc in Spring, Texas. 3 FDA inspections on record, last inspected July 13, 2018. Publicly traded as NASDAQ: LXRX.
Company Profile
This profile covers Lexicon Pharmaceuticals Inc based in Spring, Texas, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected December 18, 2013. Last inspected July 13, 2018.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 13, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1064104 |
| July 21, 2016 | NAI | Human Drugs · Bioresearch Monitoring | 985594 |
| December 18, 2013 | NAI | Human Drugs · Bioresearch Monitoring | 862908 |
FDA documents
Other FDA documents (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Lexicon Pharmaceuticals Inc
Stock ticker
LXRX
Exchange
NASDAQ
Share price
$1.82
Market cap
$810.3M
Price as of
November 13, 2026
FEI Number
3007564743
Address
8800 Technology Forest Pl, Spring, Texas 77381, United States
Country
United States
ID: 3dfbacfa-f207-4cec-b5b5-86fd14585305